Clinical Stage

I

1#

8.09#

26.35#

16.67#

II

18

7.68 (5.68 - 9.02)

24.68 (16.78 - 35.04)

17.75 (8.73 - 26.05)

III

11

7.17 (6.06 - 9.02)

21.53 (17.22 - 36.35)

16.38 (7.15 - 23.28)

IV

30

12.58 (9.14 - 27.10)

111.04 (38.09 - 302)

39.04 (7.02 - 174.23)

H(p)

60 (<0.001)*

60 (<0.001)*

1.22 (0.747)

Vascular Invasion

Negative

2

9.35 (9.22 - 9.49)

45.26 (42.0 - 48.52)

23.39 (17.65 - 29.13)

Positive

28

10.07 (5.68 - 27.10)

68.07 (16.78 - 302)

28.29 (7.02 - 174.23)

U(p)

52.0 (0.824)

52.0 (0.824)

42.0 (0.547)

Site of Metastasis

Bone

9

14.64 (9.02 - 18.49)

146.40 (36.35 - 257.22)

48.02 (7.43 - 105.01)

Lung

8

12.62 (9.49 - 15.94)

117.92 (48.52 - 253.30)

37.06 (7.02 - 56.34_

Liver

6

12.29 (9.23 - 15.94)

108.30 (46.35 - 253.30)

43.98 (14.13 - 95.76)

Other sites

7

10.17 (9.22 - 81.57)

60.07 (42 - 81.57)

25.55 (7.02 - 81.56)

H(p)

7.91 (0.048)*

7.05 (0.070)

4.70 (0.195)